AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,409 | -25.2% | 120,363 | -39.3% | 0.03% | -26.3% |
| Q1 2023 | $4,556 | +1056.3% | 198,366 | +1314.4% | 0.04% | +533.3% |
| Q4 2022 | $394 | -100.0% | 14,025 | -76.7% | 0.01% | -62.5% |
| Q2 2022 | $1,335,000 | -72.5% | 60,238 | -63.8% | 0.02% | -73.8% |
| Q1 2022 | $4,846,000 | +1220.4% | 166,459 | +1390.0% | 0.06% | +1425.0% |
| Q4 2021 | $367,000 | -68.2% | 11,172 | -55.3% | 0.00% | -75.0% |
| Q3 2021 | $1,153,000 | +428.9% | 24,978 | +530.4% | 0.02% | +700.0% |
| Q2 2021 | $218,000 | -93.9% | 3,962 | -94.2% | 0.00% | -96.2% |
| Q1 2021 | $3,546,000 | +14.3% | 68,673 | -4.1% | 0.05% | +73.3% |
| Q4 2020 | $3,102,000 | +197.7% | 71,601 | +140.5% | 0.03% | +42.9% |
| Q3 2020 | $1,042,000 | -67.5% | 29,772 | -50.3% | 0.02% | -74.7% |
| Q2 2020 | $3,204,000 | +276.5% | 59,908 | +374.7% | 0.08% | +31.7% |
| Q1 2019 | $851,000 | – | 12,621 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |